Summary
This is the second in a 3-part series on ”The Challenges of Patient Recruitment in Oncology Trials”, Senior Patient Recruitment Managers Tricia Buchheit and Lauren Johnson explore the common misconceptions which hinder patient recruitment in oncology trials and how combat and reassure patients with these reservations regarding clinical research.
You may also be interested in:
White Paper
Translating Cancer Genomics Into a Personalized Approach For Cancer Patients
This white paper provides a brief history of oncology genomics, including development, uses in improving patient care, current achievements and…
View Resource
page
Oncology
Our in-house oncology and hematology experts make the complex, simple. Our
Read More
Webcast
The Challenges of Patient Recruitment in Oncology Trials - Part 3
A Phase I through Phase III oncology trial costs approximately $56.3 million and lasts for eight years. In 2012, it was reported that a typical…
View Resource
View all related content and resources for Hematology
Explore Insights